CAS 1253491-42-7

Formule : C22H16N2O

InChI : InChI=1S/C22H16N2O/c1-25-15-9-10-20-19(13-15)18-11-12-23-21(22(18)24-20)17-8-4-6-14-5-2-3-7-16(14)17/h2-13,24H,1H3

Code InChI : AABFWJDLCCDJJN-UHFFFAOYSA-N

SMILES : COC1=CC2=C(C=C1)NC3=C2C=CN=C3C4=CC=CC5=CC=CC=C54

SP-141

CAS : 1253491-42-7

SP-141

Formule : C₂₂H₁₆N₂O

Degré de pureté : ≥98%

Masse moléculaire : 324.38

Ref: 54-BUP02569

Sp 141

CAS : 1253491-42-7

Formule : C₂₂H₁₆N₂O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 324.3752

Ref: IN-DA01E0NC

SP-141

CAS : 1253491-42-7

SP 141 is a MDM2 inhibitor.SP-141 promotes MDM2 auto-ubiquitination and degradation, with anticancer activity.

Formule : C₂₂H₁₆N₂O

Degré de pureté : 98.01%

Couleur et forme : Solid

Masse moléculaire : 324.38

Ref: TM-T21773

SP-141

CAS : 1253491-42-7

6-Methoxy-1-(naphthalen-1-yl)-9H-pyrido[3,4-b]indole

Formule : C₂₂H₁₆N₂O

Degré de pureté : 98%

Masse moléculaire : 324.38

Ref: IN-DG00797630

SP 141

Produit contrôlé

CAS : 1253491-42-7

Formule : C₂₂H₁₆N₂O

Couleur et forme : Neat

Masse moléculaire : 324.38

Ref: TR-S678500

SP 141

CAS : 1253491-42-7

SP141 is a monoclonal antibody that specifically binds to β-catenin, which is an essential component of the Wnt signaling pathway. SP141 inhibits the transcriptional activity of β-catenin, leading to reduced cell proliferation and tumor growth in CD1 mice. SP141 has been shown to induce apoptosis in various cancer cells and synergize with other types of monoclonal antibodies. SP141 was also found to be effective at reducing tumor size in human carcinoma cell lines and clinical pathology specimens.

Formule : C₂₂H₁₆N₂O

Degré de pureté : Min. 95%

Masse moléculaire : 324.38 g/mol

Ref: 3D-DAC49142